Technical Analysis for IVA - Inventiva S.A.

Grade Last Price % Change Price Change
B 4.36 3.81% 0.16
IVA closed up 3.81 percent on Monday, March 18, 2024, on 6.04 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
Earnings due: Mar 27
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up

Date Alert Name Type % Chg
New Uptrend Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Volume Surge Other 0.00%
Upper Bollinger Band Walk Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
Pocket Pivot Bullish Swing Setup 3.81%

   Recent Intraday Alerts

Alert Time
Up 5% about 15 hours ago
Up 1 ATR about 15 hours ago
60 Minute Opening Range Breakdown about 15 hours ago
Upper Bollinger Band Resistance about 15 hours ago
5x Volume Pace about 17 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Inventiva SA engages in the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis and related diseases. It owns an in-house drug-discovery platform that develops internal oncology and fibrosis discovery pipeline with approaches centred on transcription factors, epigenetics targets, and nuclear receptors. The company was founded by Pierre Broqua and Frédéric Cren on October 27, 2011 and is headquartered in Daix, France.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biology Alcohol Genetics Gene Expression Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease DNA Fibrosis Small Molecule Therapies Transcription Transcription Factors Epigenetics Transcription Factor Hepatitis A

Is IVA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.04
52 Week Low 2.22
Average Volume 30,901
200-Day Moving Average 3.97
50-Day Moving Average 3.84
20-Day Moving Average 3.73
10-Day Moving Average 3.92
Average True Range 0.24
RSI (14) 66.44
ADX 26.2
+DI 34.05
-DI 10.17
Chandelier Exit (Long, 3 ATRs) 3.78
Chandelier Exit (Short, 3 ATRs) 3.93
Upper Bollinger Bands 4.31
Lower Bollinger Band 3.14
Percent B (%b) 1.04
BandWidth 31.28
MACD Line 0.11
MACD Signal Line 0.02
MACD Histogram 0.0828
Fundamentals Value
Market Cap 225.18 Million
Num Shares 51.6 Million
EPS -2.05
Price-to-Earnings (P/E) Ratio -2.13
Price-to-Sales 8.77
Price-to-Book 2.64
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.86
Resistance 3 (R3) 4.85 4.67 4.77
Resistance 2 (R2) 4.67 4.55 4.68 4.74
Resistance 1 (R1) 4.52 4.47 4.60 4.53 4.72
Pivot Point 4.34 4.34 4.38 4.35 4.34
Support 1 (S1) 4.19 4.22 4.27 4.20 4.00
Support 2 (S2) 4.01 4.14 4.02 3.98
Support 3 (S3) 3.86 4.01 3.95
Support 4 (S4) 3.87